Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Opravil

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
AIDS (London, England)|December 28, 2000
Impact of TNFalpha, LTalpha, Fc gammaRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patientsM C Knuchel, R F Speck, E Schlaepfer, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
The New England Journal of Medicine|April 18, 1991
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumoniaB Hirschel, A Lazzarin, P Chopard, et al.
Antiviral Therapy|March 21, 2000
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort StudyO T Rutschmann, M Opravil, A Iten, et al.
Archives of Internal Medicine|February 27, 1995
Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort StudyM Pechère, M Opravil, A Wald, et al.
Archives of Internal Medicine|July 10, 1999
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort StudyR Weber, B Ledergerber, R Zbinden, et al.
AIDS (London, England)|April 15, 1999
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort StudyP Lorenzi, M Opravil, B Hirschel, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapyM Fischer, H F Günthard, M Opravil, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
HIV Medicine|January 26, 2008
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006A Nguyen, A Calmy, V Schiffer, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|December 28, 2000
Impact of TNFalpha, LTalpha, Fc gammaRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patientsM C Knuchel, R F Speck, E Schlaepfer, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
The New England Journal of Medicine|April 18, 1991
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumoniaB Hirschel, A Lazzarin, P Chopard, et al.
Antiviral Therapy|March 21, 2000
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort StudyO T Rutschmann, M Opravil, A Iten, et al.
Archives of Internal Medicine|February 27, 1995
Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort StudyM Pechère, M Opravil, A Wald, et al.
Archives of Internal Medicine|July 10, 1999
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort StudyR Weber, B Ledergerber, R Zbinden, et al.
AIDS (London, England)|April 15, 1999
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort StudyP Lorenzi, M Opravil, B Hirschel, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapyM Fischer, H F Günthard, M Opravil, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
HIV Medicine|January 26, 2008
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006A Nguyen, A Calmy, V Schiffer, et al.
Pageof 12